Tonix Pharmaceuticals Holding Corp.
(NASDAQ:TNXP) shares are trading higher Monday after the company secured a second commercial payer agreement for TONMYA, its recently launched fibromyalgia treatment.
Tonix stock is among today's top performers.
Why is TNXP stock up today?
Expanding Coverage The agreement, effective June 1, 2026, was reached with a second leading group purchasing organization (GPO) and provides coverage for TONMYA to an additional approximately 17 million U.S. commercial lives — roughly 10% of the 177 million total commercial lives in the U.S.
